ALTERNATING VERSUS CONTINUOUS DRUG REGIMENS IN COMBINATION CHEMOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN-VITRO

被引:30
作者
MAZZULI, T
RUSCONI, S
MERRILL, DP
DAQUILA, RT
MOONIS, M
CHOU, TC
HIRSCH, MS
机构
[1] HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,INFECT DIS UNIT,GRAYS 5,FRUIT ST,BOSTON,MA 02114
[2] MEM SLOAN KETTERING CANC CTR,BIOCHEM PHARMACOL LAB,NEW YORK,NY 10021
关键词
D O I
10.1128/AAC.38.4.656
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We compared the in vitro efficacies of two-, three-, and four-drug combinations given continuously or in alternating regimens against a clinical isolate of human immunodeficiency virus type 1. In H9 cells and peripheral blood mononuclear cells, at the drug concentrations used in this study, there was greater suppression of human immunodeficiency virus type 1 infection as the number of drugs in the regimen was increased from one to four simultaneously administered agents. Although alternating drug regimens were effective, they were not better than continuous administration of either single drugs or combinations of agents and were less effective than giving all drugs of an alternating regimen simultaneously.
引用
收藏
页码:656 / 661
页数:6
相关论文
共 38 条
[1]   COMBINED TREATMENT OF SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION WITH NATIVE INTERFERON-ALPHA AND ZIDOVUDINE [J].
BERGLUND, O ;
ENGMAN, K ;
EHRNST, A ;
ANDERSSON, J ;
LIDMAN, K ;
AKERLUND, B ;
SONNERBORG, A ;
STRANNEGARD, O .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :710-715
[2]   The toxicity of poisons applied jointly [J].
Bliss, CI .
ANNALS OF APPLIED BIOLOGY, 1939, 26 (03) :585-615
[3]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN-VITRO BY THE BISHETEROARYLPIPERZINE ATEVIRDINE (U-87201E) IN COMBINATION WITH ZIDOVUDINE OR DIDANOSINE [J].
CAMPBELL, TB ;
YOUNG, RK ;
ERON, JJ ;
DAQUILA, RT ;
TARPLEY, WG ;
KURITZKES, DR .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) :318-326
[4]  
Chou J. H., 1989, DOSE EFFECT ANAL MIC
[5]  
Chou T, 1991, SYNERGISM ANTAGONISM, V1, P61
[6]   DETERMINATION OF AVAILABILITY OF LIGAND-BINDING SITES IN STEADY-STATE SYSTEMS [J].
CHOU, TC .
JOURNAL OF THEORETICAL BIOLOGY, 1977, 65 (02) :345-356
[7]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[8]   USE OF EVOLUTIONARY LIMITATIONS OF HIV-1 MULTIDRUG RESISTANCE TO OPTIMIZE THERAPY [J].
CHOW, YK ;
HIRSCH, MS ;
MERRILL, DP ;
BECHTEL, LJ ;
ERON, JJ ;
KAPLAN, JC ;
DAQUILA, RT .
NATURE, 1993, 361 (6413) :650-654
[9]   A PHASE-I/II TRIAL OF ZIDOVUDINE, INTERFERON-ALPHA, AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAVEY, RT ;
DAVEY, VJ ;
METCALF, JA ;
ZURLO, JJ ;
KOVACS, JA ;
FALLOON, J ;
POLIS, MA ;
ZUNICH, KM ;
MASUR, H ;
LANE, HC .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (01) :43-52
[10]   U-90152, A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION [J].
DUEWEKE, TJ ;
POPPE, SM ;
ROMERO, DL ;
SWANEY, SM ;
SO, AG ;
DOWNEY, KM ;
ALTHAUS, IW ;
REUSSER, F ;
BUSSO, M ;
RESNICK, L ;
MAYERS, DI ;
LANE, J ;
ARISTOFF, PA ;
THOMAS, RC ;
TARPLEY, WG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1127-1131